US Broker Ratings

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 49.67% Potential Upside in the Medical Device Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, is a medical technology company with a strong presence in the medical devices industry. With a market capitalization of..

HUTCHMED (China) Limited (HCM): Growth Potential with a 53% Upside and Strong Analyst Support

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, is capturing investor attention with its potential growth trajectory and robust analyst endorsement...

Organon & Co. (OGN) Stock Analysis: Understanding the 47.78% Potential Upside in a Turbulent Market

As investors explore the dynamics of the healthcare sector, Organon & Co. (NYSE: OGN) presents a compelling narrative. With its roots in Jersey City, New Jersey, Organon has carved out..

Arcellx, Inc. (ACLX) Stock Analysis: Navigating the Biotech Landscape with a $6.7 Billion Market Cap

Arcellx, Inc. (ACLX), a rising star in the biotechnology sector, is making waves with its ambitious pipeline focused on innovative immunotherapies. Headquartered in Redwood City, California, Arcellx is carving its..

Alvotech (ALVO) Stock Analysis: Exploring a 365% Upside Potential in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based healthcare company specializing in biosimilar medicines, presents a compelling opportunity for investors seeking exposure to the burgeoning biosimilars market. With a market capitalization of $1.04..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 53% Upside Potential

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company headquartered in Zug, Switzerland, is garnering attention for its innovative approach to treating inflammatory skin and joint diseases. With a market capitalization..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a Promising 50% Upside Potential

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its compelling growth narrative and..

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a 48% Upside Potential in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA) stands at the forefront of the healthcare sector, providing innovative solutions within the health information services industry. With a market capitalization of $2.66 billion,..

Apogee Therapeutics (APGE) Stock Analysis: Strong Buy Ratings and a 31.67% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE), a clinical-stage biotechnology firm, is attracting significant attention from investors, thanks to its innovative pipeline and promising analyst ratings. With a market capitalization of $5.46..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking the 45% Potential Upside in Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) is making waves in the biotechnology sector with its promising pipeline of neurological and psychiatric treatments. The Canadian company, boasting a market capitalization of $5.19..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech with Promising 28.43% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention with its considerable potential upside of 28.43%, according to analyst ratings. As a biopharmaceutical company dedicated to transforming the treatment..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 40.59% Potential Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a stalwart in the healthcare sector specializing in medical instruments and supplies, has piqued investor interest with its promising growth potential. The company, headquartered in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: 24.45% Potential Upside Sparks Investor Interest

Krystal Biotech, Inc. (NASDAQ: KRYS), a dynamic player in the biotechnology sector, is drawing significant attention from investors with a market cap of $7.36 billion and a compelling 24.45% potential..

Integer Holdings Corporation (ITGR) Stock Analysis: Assessing the 10.88% Potential Upside in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in the development and manufacturing of medical devices across its various global locations. With a market capitalization..

Regencell Bioscience Holdings (RGC): Analyzing the $13.53 Billion Market Cap in the TCM Sector

For investors seeking opportunities in the healthcare sector, particularly within the realm of Traditional Chinese Medicine (TCM), Regencell Bioscience Holdings Limited (NASDAQ: RGC) deserves a closer look. Based in Hong..

Inspire Medical Systems, Inc. (INSP): Growth Potential in Innovative Sleep Apnea Solutions with a 43.60% Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge solutions for obstructive sleep apnea (OSA)...

Globus Medical, Inc. (GMED) Stock Analysis: Unveiling a 26.72% Potential Upside for Investors

Globus Medical, Inc. (NYSE: GMED) stands out in the medical devices industry with its robust portfolio of healthcare solutions aimed at treating musculoskeletal disorders. As a key player in the..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: 57% Upside Potential Amidst Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company, is making waves in the biotechnology sector with a compelling 57.35% potential upside. With a market capitalization of $5.97 billion, Rhythm..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a 141.96% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX) is capturing the attention of investors with its strategic positioning in the healthcare sector, particularly within the dynamic biotechnology industry. Based in North Melbourne, Australia,..

Elanco Animal Health (ELAN) Stock Analysis: A 20% Upside Potential Amid Robust Revenue Growth

Elanco Animal Health Incorporated (NYSE: ELAN), a formidable player in the healthcare sector focusing on drug manufacturing for specialty and generic markets, is currently drawing investor attention with its promising..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds